ABSTRACT The dual roles of baculovirus for the control of natural insect populations as an insecticide, and for 12 foreign gene expression and delivery, have called for a comprehensive understanding of the molecular mechanisms 13 governing viral infection. Here, we demonstrate that the Bombyx mori Niemann-Pick C1 (BmNPC1) is essential for 14 baculovirus infection in insect cells. Both pretreatment of Bombyx mori embryonic cells (BmE) with NPC1 antagonists 15 (imipramine or U18666A) and down-regulation of NPC1 expression resulted in a significant reduction in baculovirus 16
(represented by relative copy number of gp41) decreased significantly at concentrations of 50-100 µM for imipramine 109 and at concentrations of 1-10 µM for U18666A. For BmE cells pretreated with 100 µM of imipramine or 10 µM of 110 U18666A, the viral load was reduced to 27% and 10%, respectively, compared to the vehicle along treatment control 111 (Fig 2D, 2F ). In summary, we conclude that blockage of BmNPC1 function by small molecules can efficiently reduce 112
BmNPV infection in BmE cells, indicating that functional BmNPC1 is required for BmNPV infection in insect cells. 113

Knockdown of BmNPC1 expression by RNAi reduced virus infection in BmE cells. To further study the role 114
of BmNPC1 in BmNPV infection, two sets of RNAi vectors targeting BmNPC1 (psl-BmNPC1-a and psl-BmNPC1-b) 115
were constructed (Fig 3A) , and independently transfected into BmE cells. The reduction of BmNPC1 expression at the 116 mRNA level following BmNPC1-RNAi treatment was detected by qPCR at various time points post transfection (p.t.). 117 psl-BmNPC1-b was selected to knock down BmNPC1 expression in BmE cells due to greater efficiency and duration 118 in reducing the expression of BmNPC1 (40% of reduction compared to psl-null at 48 h, with the knock-down effect 119 persisting until 96 h p.t.) (Fig 3B) . BmE cells were treated with psl-BmNPC1-b or psl-null for 48 h prior to infection 120 with BmNPV-GFP. As shown in Fig 3C and 3D , viral infectivity as indicated by GFP expression was decreased 121 significantly in psl-BmNPC1-b treated cells at 48, 72 and 96 h p.i. compared to that in control RNAi treated cells. 122
Furthermore, viral loads represented by relative copy number of gp41 in BmNPC1 RNAi treated cells was less than 123 10% of that in control RNAi-treated cells at 72 h p.i. (Fig 3E) . The viral titer (5.6 log 10 TCID 50 /ml) at 96 h p.i. as 124 quantified by TCID 50 in BmNPC1 RNAi treated cells was significantly lower compared to that in control cells (10.8 125 log 10 TCID 50 /ml, Fig 3F) . Collectively, we conclude that knocking down BmNPC1 by RNAi expression in BmE cells 126 can substantially reduce BmNPV infectivity. 127
BmNPC1 null stable cell line was resistant to BmNPV infection. To further confirm that BmNPC1 is essential 128
for BmNPV infection, we generated a BmNPC1 null stable cell line by using CRISPR-Cas9 technology. Partial 129 BmNPC1 gene was replaced by ie1-DsRed and A3-neo expression cassettes (Fig S3B) , and the mutated BmNPC1 gene 130 was confirmed by PCR amplification and sequencing (Fig S3D) . We next tested the susceptibility of the NPC1-mutant 131 cells to BmNPV-GFP virus infection, and found that the percentage of GFP positive cells among BmNPC1-null cells as 132 indicated by the expression of red fluorescence was less than 2% of that of the control cells at 96 h p.i. (Fig 4A and  133 4B). Concurrently, the virus load as evaluated by relative copy number of gp41 was reduced to 20% of that in control 134 cells (Fig 4C) . Altogether, these data confirmed that BmNPC1 is required for BmNPV infection, and the cells lacking 135 functional BmNPC1 exhibit substantially reduced susceptibility for BmNPV infection.
hNPC1 is able to interact with a primed form of Ebola virus glycoprotein GP, the primary glycoprotein responsible for 138 receptor binding and fusion (18, 25) . To investigate whether BmNPC1 contributes to BmNPV infection by interacting 139 with glycoprotein gp64 during viral entry, we performed Co-immunoprecipitation with in-vitro expressed proteins 140 (BmNPC1 domain A, C, I and BmNPV gp64). Gp64-attached protein G agarose beads through mouse anti-gp64 141 antibody were incubated with BmNPC1 domain-specific proteins (domain A, C and I, respectively) for 142 immunoprecipitation. The proteins that bound to the beads, i.e. the co-immunoprecipitation samples were then analyzed 143 by Western blot. As shown in Fig 5A, gp64 proteins could be detected in the immune pellets by gp64 monoclonal 144 antibody. The same immune pellets were subsequently probed with anti-HA antibody, and a specific band 145 corresponding to the NPC1 domain A, C and I in each individual blot was shown in Fig 5B, and the band 146 corresponding to NPC1-C displaying the strongest signal. Our results suggest that gp64 is able to interact with distinct 147 domains (A, C and I) of the NPC1 protein, with the strongest binding affinity for NPC1-C. Next, we performed the 148 reciprocal co-immunoprecipitation experiments, in which NPC1 domain specific protein-attached beads were used to 149 immune-precipitate gp64 proteins. The presence of NPC1-A, C or I in the retrieved beads was confirmed with anti-HA 150 antibody (Fig 5C) , however, the band corresponding to gp64 was only present in the NPC1-C-attached immune pellets 151 (Fig 5D) . Our results suggest that domain C of BmNPC1 is sufficient for gp64 binding, while in comparison, the 152 binding affinity of BmNPC1-A or BmNPC1-I to gp64 is relatively low. 153
To further confirm these interactions, we employed a yeast two-hybrid system (Y2H). Full-length gp64 was cloned 154 into the pGBKT7 vector as bait, and BmNPC1-A, BmNPC1-C, BmNPC1-I were used as the prey. These Y2H screens 155 revealed that BmNPC1-C interacted with full-length gp64, whereas BmNPC1-A or BmNPC1-I bound to gp64 with a 156 weak affinity (Fig S4) . Collectively, these results demonstrate a specific interaction between BmNPC1 domain C and 157
BmNPV gp64. 158
Next, we investigated whether the interaction between BmNPV gp64 and BmNPC1 domain C was pH dependent. 159
For this purpose, the Co-IP between BmNPV gp64 and BmNPC1-C was performed at pH 5 or 8. NPC1-C and gp64 160 proteins were expressed with His tag in vitro, and then the protein mixtures were incubated with protein G beads that 161 had been conjugated with mouse monoclonal antibody to gp64. Anti-His antibody was used to detect both gp64 and 162 NPC1-C at the same blot for more accurate comparison. As shown in Fig 5E, we found a stronger BmNPC1-C signal atpH 5 compared to that at pH 8, indicating that BmNPV gp64 binding affinity to BmNPC1-C was enhanced at a lower 164 (Fig 5F and 5G ). These data suggest that the interaction between 171
BmNPC1 domain C and BmNPV gp64 is essential for BmNPV infection in BmE cells. 172
173
DISCUSSION 174
Baculoviruses have been widely used as important biological agents for controlling insect populations, and 175 powerful biological tools for gene delivery and expression; a better understanding of the molecular mechanisms and 176 host factors involved in baculovirus virus entry is of great significance in bioscience and biotechnology. In this study, 177
we used the well-studied baculovirus BmNPV as a tool to investigate the host factor requirements for baculovirus 178 infection, and found that BmNPC1, the hNPC1 homolog in insect cells, is indispensable for BmNPV infection in insect 179 cells. Our results, together with previous work identifying a role for hNPC1 as an intracellular receptor for Ebola virus 180 entry, have revealed that the conserved host protein NPC1, essential for cholesterol homeostasis, has been exploited by 181 a group of divergent viruses for entry. 182
As an essential component of cellular membranes, cholesterol is one of the most important lipids for maintaining 183 cell viability, cell signaling and physiology (28, 29) . Two major proteins that function in cholesterol transport are 184 NPC1 and NPC2. NPC2 is the central shuttle in a unidirectional transfer pathway that mobilizes cholesterol to NPC1, 185 leading to NPC1 export of cholesterol from late endosomes (16, 23, 24, 30) . Recently, it has been demonstrated that 186 filoviruses, including Ebola and Marburg viruses, utilize NPC1 as intracellular receptors for entry (18). Interestingly, in 187 addition to Ebola virus (family: Filoviridae), hepatitis C virus (family: Flaviviridae) entry also requires the cholesterol 188 trafficking receptor Niemann-Pick C1-Like 1 (NPC1L1) (31), a NPC1 paralog which serves in cellular cholesterol 189 absorption and homeostasis on the apical surface of intestinal enterocytes and human hepatocytes (20, 32). Moreover,the release of HIV-1 (family: Retroviridae) (33) and Chikungunya virus (family: Togaviridae) (27) is impaired in cells 191 from patients with NPC disease. U18666A or imipramine, which mimics a NPC-deficient phenotype, also strongly 192 inhibits the replication of several flaviviridae family members, including Zika, West Nile, and Dengue viruses (27). In 193 our study, we present evidence that baculovirus utilizes the NPC1 homolog to enter into insect cells. Although the 194 enveloped viruses described above belong to distinct viral families (Baculoviridae, Filoviridae, Togaviridae and 195 Flaviviridae), and possess different types (dsDNA, +ssRNA or -ssRNA) and sizes of viral genomes, they invariably 196 hijack NPC1 in the cholesterol transport pathway to initiate infection. We speculate that NPC1 is the common entry 197 receptor for many enveloped viruses during cellular infection. However, it should be noted that infection with some 198 binding between hNPC1 and GPcl was hypothesized to facilitate fusion between vial membrane and host endosomal 206 membranes (23). In contrast, the BmNPV glycoprotein gp64 is a Class III fusion protein, and viral fusion is triggered 207 by a caustic pH without proteolytic cleavage. We show here that BmNPC1 proteins are located at both the cell plasma 208 membrane and intracellular compartments, and that BmNPC1 is capable of binding to gp64 at a neutral pH, indicating 209 that BmNPC1 may serve as a host factor to facilitate virus attachment to the cell surface. The enhanced binding 210 between BmNPC1 and gp64 at a lower pH as demonstrated in our study suggests that low pH triggered-conformational 211 changes in the gp64 protein may expose certain epitopes or domains to allow better accessibility by BmNPC1, and the 212 specific binding between gp64 and BmNPC1 may ultimately enable gp64 to maintain a certain structure which is 213 essential for targeting its fusion domain into the endosomal membranes. However, the detailed mechanism of BmNPC1 214 protein in baculovirus entry will rely on future crystallographic examination of the BmNPC1 and gp64 complex. Such 215 studies will ultimately shed light on how a wide range of enveloped viruses utilize the shared host factor NPC1 as part 216 of fusion triggers for intracellular entry.
Baculovirus
conserved host factors may be involved in viral entry. In our study, we have only examined the role of NPC1 in viral 219 entry in insect cells; it will be of great interest in the future to assess whether NPC1 is involved in viral entry in 220 mammalian cells. Furthermore, the cell surface localization of BmNPC1 in insect cells raises the possibility that 221
BmNPC1 (Fig. 6 ). In this model, baculovirus binds to the cell surface with the possibility of using BmNPC1 as one of the 225 attachment factors, and is then internalized and trafficked to late endosomes. In the caustic pH environment of 226 endosomes, gp64 undergoes conformational changes to expose certain domain(s) for better access by BmNPC1. The 227 specific binding between gp64 and BmNPC1 subsequently facilitates viral fusion events to allow nucleocapsids to be 228 by 50% tissue culture infectious dose (TCID 50 ) based on EGFP expression as described (37). 242
Cloning, protein expression, and purification of BmNPC1 and antibody production. The BmNPC1 243 transmembrane domain was predicted based on the website (http://www.cbs.dtu.dk/services/TMHMM-2.0/), andfunctional domains were predicted based on the website (http://smart.embl-heidelberg.de/). The full coding region of 245 BmNPC1 was PCR amplified with specific primer (Table S1 ) from a BmE cell cDNA library and then cloned into the 246 pMD19-T vector for sequencing. The sequences of BmNPC1 extracellular loop A (31 to 264 amino acids) or I (881 to 247 1152 amino acids) were amplified with primer pairs BmNPC1-A-PE and BmNPC1-I-PE (Table S1) anti-BmNPC1-I mouse serum, anti-BmNPC1 rabbit serum, and control sera from both naïve mice and rabbits immunized 255 with KLH tag only were collected and stored at -20˚C until use. 256
BmNPC1-RNAi construction and transfection in BmE cells. The RNAi target prediction of BmNPC1 was 257
performed according to the website (http://jura.wi.mit.edu/bioc/siRNA); two regions designated npc1-a and npc1-b 258 were chosen based on scores for subsequent use. The sense and antisense fragments of npc1-a and npc1-b were 259 amplified from the BmE genome with primer pairs npc1-RNAi-a and npc1-RNAi-b (Table S1) , and were subsequently 260 cloned into the RNAi vector pSL1180 with A3 intron as a spacer (3) (Fig 3A) , generating RNAi vectors 261 psl-BmNPC1-a and psl-BmNPC1-b. Unmodified pSL1180 vector designated as psl-null was used as a negative control 262 for RNAi. 263
BmE cells (7 × 10 5 cells/well) grown in six-well culture plates were transfected with 2 μg of psl-BmNPC1-a or 264 psl-BmNPC1-b, or negative control psl-null siRNA, using 2 μl of X-treme GENE HP DNA tranfection reagent (Roche, 265 Germany) following the manufacturer's protocol for 48h before cells were subjected to viral infection. The knockdown 266 effect of RNAi transfection was confirmed by mRNA expression via qPCR with primer set BmNPC1-q (Table S1) . 267
Construction and verification of NPC1-knockout (ΔNPC1) BmE cells. The CRISPR/Cas9 genomic editing tool 268 was used to generate the stable BmNPC1-knockout BmE cell line. The Cas9 expression vector (named 269 pSL1180-IE1-Cas9) and sgRNA expression vector (named PUC57-U6-gRNA) were constructed as previously 270 described (38) (Fig S3A) . The primer sequences generating the guide RNA (gRNA) targeting the BmNPC1 genes were 271 designed based on the CRISPR website (http://crispr.dbcls.jp/); all candidate sgRNA target sequences bear the 272 GN19NGG sequence. Next, extraction of two optimal target sites (gRNA-1 and gRNA-2) based on the CRISPR 273 website (http://crispr.dbcls.jp/) was performed; the forward and reverse primers of the target sequence start with AAGT 274 and AAAC, respectively. The corresponding oligos were annealed and ligated into a sgRNA expression vector which 275 was digested by Bbs I to generate sgRNA-1 and sgRNA-2 expression plasmids. All sgRNA expression plasmids were 276 sequenced by M13 primers for verification. For construction of the BmNPC1 replacement donor vector, homologous 277 arms targeted upstream of the gRNA-1 site and downstream of the gRNA-2 site were amplified from Bombyx mori 278 genomic DNA and designated as Left-HR and Right-HR, respectively. The selective markers ie1-DsRed-sv40 and 279 A3-neo-sv40 were maintained in our laboratory. The Left-HR, DsRed expression cassettes, neomycin (neo) expression 280 cassettes, and Right-HR were sequentially cloned into the pBluescript II KS (-) vector to generate the donor plasmid 281 pKS-donor (Fig S3B) . All clones were verified by sequencing of plasmids. The primers are listed in Supplemental 282 Table S1 . 283
Reverse transcriptase PCR and Quantitative real-time PCR (qPCR).
Total RNA from BmE cell was extracted 284 using Total RNA kit II (Omega, USA) following manufacturer's protocol, and reverse transcription was carried out 285 using MLV Reverse Transcriptase (Promega, USA). These cDNA samples were used to detect transcripts of BmNPC1 286 using the primers BmNPC1-q (Table S1 ). The BmRPL3 (gi|112982798) amplified with primers BmRPL3-q (Table S1 ) 287 was used as the internal reference. Sample analysis was performed on the CFX96 TM Real-Time System (Biorad, 288
France). 289
The viral DNA loads were calculated based on qPCR of the BmNPV gp41 gene. Total DNA from each sample was 290 prepared with a Wizard Genomic DNA extraction Kit (Promega, USA) according to the manufacturer's protocol, and 291 the qPCR was performed using primers gp41-q (Table S1 ) targeting a 120-bp region of the BmNPV gp41 gene 292 (AAC63752.1). The BmGAPDH gene amplified by primers BmGAPHG-q (Table S1 ) was used as the reference. 293 Viral infection and quantification of infectivity. BmE cells or ΔNPC1-BmE cells (7 × 10 5 cells/well) seeded into 294 six-well culture plates were inoculated with BmNPV-GFP virus at an MOI of 1 for 2 h, after which cells were washed 295 three times with serum-free Grace medium followed by incubation with Grace medium supplemented with 10% FBS. independent experiments. Next, the ΔNPC1-BmE cells were collected based on DsRed expression by flow cytometry 299 (Fig S3C) , and viral DNA loads were determined by relative quantification of viral gp41 gene using qPCR and were 300 expressed as the fold of change compared to the corresponding control. Viral titers in RNAi-NPC1 cells were 301 determined with a TCID 50 endpoint dilution assay based on the GFP expression positive cells. following the manufacturer's protocol (Thermo Fisher Scientific, USA). A, C, and I-domains of BmNPC1 were 312 expressed with His 9 -tag and GST-tag to the N-terminus and a HA-tag to the C-terminus; gp64 protein were only 313 expressed with His 9 -tag and GST-tag to the N-terminus (not include a HA-tag). The expression of recombinant proteins 314 was confirmed by Western blot using anti-HA monoclonal antibody (Sigma-Aldrich, USA) or anti-gp64 monoclonal 315 antibody (Abcom, UK). Co-immunoprecipitation was performed in accordance with standard protocols to probe the 316 interaction between gp64 and BmNPC1 proteins. In brief, the protein G agarose beads (BioRad, USA) bearing gp64 317 protein through mouse anti-gp64 antibody were incubated with NPC1-A, NPC1-C or NPC1-I protein overnight at 4°C 318 with gentle shaking. Proteins eluted from the beads were probed with anti-HA monoclonal antibody via Western blot. 319
Co-immunoprecipitation was also performed in a reciprocal manner; in which NPC1-A, NPC1-C, and NPC1-I 320 conjugated beads were incubated with gp64 protein, with proteins eluted from the beads probed with mouse anti-gp64 321 monoclonal antibody. 322
Yeast two-hybrid assay. The yeast two-hybrid assay was used to confirm the interaction between NPC1-A, 323 NPC1-C, NPC1-I and gp64 in vivo according to the previously described (39). The bait and prey constructs pairs 324 pGBKT7-gp64/pGADT7-NPC1-A, pGBKT7-gp64/pGADT7-NPC1-C, pGBKT7-gp64/pGADT7-NPC1-I, andpGBKT7-NPC1-C /pGADT7-gp64 were transformed simultaneously into competent yeast cells to examine the protein 326 interaction. All primers used are listed in Supplemental Table S1 . 327
Immunofluorescence assay (IFA). BmE cells grown on cover glasses in 12-well plates (Corning, USA) for 12h at 328 28°C, then were fixed by 4% paraformaldehyde at room temperature for 30 min followed by permeabilization with 329 0.2% Triton X-100 or without permeabiliztion. The cells were stained with PcAb-hNPC1 antibody (Abcom, UK) or 330 negative rabbit IgG for immunofluorescence microscopy as described previously (40), and imaged with an Olympus 331 confocal microscope. 332 Antibody blocking assay. BmE cells (2 × 10 5 cells/well) seeded in twelve-well culture plates were incubated with 333 one of the following antibodies: mouse anti-NPC1-A,anti-NPC1-I polyclonal antibody, rabbit anti-NPC1-C polyclonal 334 antibody, mouse or rabbit naïve serum, at a concentration of 10 μg/ml for 2h at 28˚C, after which cells were infected 335 with BmNPV-GFP at an MOI of 3. At 72 h p. i. infected cells were fixed for microscopy and the supernatants were 336 harvested for measuring viral DNA load by qPCR as described previously. 337
Statistics. Independent-samples T tests were used for statistical analysis. Significant differences are marked with * 338 at P < 0.05, ** at P < 0.01 and *** at P < 0.001; n.s, non-significant, respectively. All results are graphed as means ± 339 SD for triplicate samples. All the data presented are representative of a minimum of three independent experiments. 340 
